PDT Partners LLC Trims Stock Holdings in agilon health, inc. (NYSE:AGL)

PDT Partners LLC lowered its stake in agilon health, inc. (NYSE:AGL - Free Report) by 86.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 50,324 shares of the company's stock after selling 309,082 shares during the quarter. PDT Partners LLC's holdings in agilon health were worth $198,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. CWM LLC increased its stake in shares of agilon health by 406.5% during the second quarter. CWM LLC now owns 9,081 shares of the company's stock valued at $59,000 after buying an additional 7,288 shares during the period. Simplicity Wealth LLC increased its stake in shares of agilon health by 145.1% during the second quarter. Simplicity Wealth LLC now owns 26,210 shares of the company's stock valued at $171,000 after buying an additional 15,515 shares during the period. J.Safra Asset Management Corp increased its stake in shares of agilon health by 626.1% during the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company's stock valued at $27,000 after buying an additional 3,625 shares during the period. Nisa Investment Advisors LLC purchased a new position in shares of agilon health during the second quarter valued at approximately $60,000. Finally, Neo Ivy Capital Management purchased a new position in shares of agilon health during the second quarter valued at approximately $1,006,000.

agilon health Stock Performance

Shares of NYSE:AGL traded down $0.02 during midday trading on Thursday, reaching $2.21. 3,289,561 shares of the company's stock traded hands, compared to its average volume of 4,894,209. The company has a market cap of $910.56 million, a price-to-earnings ratio of -2.31 and a beta of 0.51. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. agilon health, inc. has a one year low of $1.50 and a one year high of $13.76. The stock has a 50 day moving average of $2.63 and a 200 day moving average of $4.56.

agilon health (NYSE:AGL - Get Free Report) last posted its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The firm had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. During the same period in the prior year, the company posted ($0.06) EPS. As a group, equities research analysts anticipate that agilon health, inc. will post -0.47 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

AGL has been the topic of several research analyst reports. Stifel Nicolaus reduced their target price on agilon health from $7.00 to $2.00 and set a "hold" rating on the stock in a research note on Tuesday, November 12th. William Blair cut agilon health from an "outperform" rating to a "market perform" rating in a research note on Friday, November 8th. Evercore ISI reduced their price target on agilon health from $7.00 to $4.00 and set an "in-line" rating on the stock in a research note on Tuesday, October 8th. TD Cowen reduced their price target on agilon health from $6.00 to $2.00 and set a "hold" rating on the stock in a research note on Monday, November 11th. Finally, Bank of America cut agilon health from a "buy" rating to an "underperform" rating and set a $3.00 price target on the stock. in a research note on Wednesday, October 2nd. Three analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $6.05.

Insider Buying and Selling at agilon health

In other news, CEO Steven Sell bought 20,000 shares of the stock in a transaction on Thursday, September 12th. The shares were bought at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the acquisition, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. The trade was a 42.03 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 3.20% of the stock is owned by corporate insiders.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.